Related Experiment Video
Updated: Dec 7, 2025

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
MicroRNA‑214 promotes the EMT process in melanoma by downregulating CADM1 expression
Shu-Jun Wang1, Wei-Wei Li1, Cong-Ji Wen1
1Department of Plastic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China.
Abstract:
Melanoma is a malignant skin cancer type associated with a high mortality rate, but its treatment is currently not ideal. Both microRNA (miR)‑214 and cell adhesion molecule 1 (CADM1) are differentially expressed in melanoma, but their role in this cancer type remains unknown. Therefore, the aim of the present study was to investigate the role of CADM1 and miR‑214 in melanoma to identify novel targets for its treatment. The expression levels of CADM1 and miR‑214 in cells were detected by reverse transcription‑quantitative PCR (RT‑qPCR). Moreover, cell viability, migration and invasion were measured by MTT, wound healing and Transwell assays, respectively. In addition, the relative expression levels of epithelial‑mesenchymal transition (EMT)‑related proteins in cells were detected by RT‑qPCR and western blotting. It was found that the expression of CADM1 was inhibited in melanoma cells, while miR‑214 expression was increased during melanoma tumorigenesis. Furthermore, miR‑214 mimics promoted the viability, migration and invasion of melanoma cells. It was also demonstrated that the downregulation of CADM1 reversed the inhibitory effect of the miR‑214 inhibitor in melanoma. Moreover, overexpression of CADM1 inhibited the EMT process in melanoma, while the miR‑214 inhibitor suppressed the EMT process. The results also indicated that miR‑214 promoted the EMT process by downregulating CADM1, which may represent a novel mechanism for the progression of melanoma.
Insights
MicroRNA-214 promotes melanoma progression by downregulating cell adhesion molecule 1 (CADM1), suggesting novel therapeutic targets for this skin cancer. This finding highlights a new mechanism in melanoma development.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- Melanoma is a deadly skin cancer with limited treatment options.
- MicroRNA-214 (miR-214) and cell adhesion molecule 1 (CADM1) are altered in melanoma, but their roles are unclear.
Purpose of the Study:
- To investigate the roles of CADM1 and miR-214 in melanoma.
- To identify potential therapeutic targets for melanoma treatment.
Main Methods:
- Quantitative PCR (RT-qPCR) and Western blotting for gene and protein expression.
- Cell viability, migration, and invasion assays (MTT, wound healing, Transwell).
- Analysis of epithelial-mesenchymal transition (EMT) markers.
Main Results:
- CADM1 expression was reduced, while miR-214 expression was elevated in melanoma cells.
- miR-214 mimics increased melanoma cell viability, migration, and invasion.
- CADM1 downregulation counteracted miR-214 inhibitor effects; CADM1 overexpression inhibited EMT.
Conclusions:
- miR-214 promotes melanoma progression and epithelial-mesenchymal transition (EMT) by downregulating CADM1.
- The miR-214/CADM1 axis represents a potential therapeutic strategy for melanoma.
Related Concept Videos
MicroRNAs
MicroRNAs
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
MAPK Signaling Cascades
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

